Literature DB >> 24276754

Activation of prosurvival signaling pathways during the memory phase of volatile anesthetic preconditioning in human myocardium: a pilot study.

Kyriakos Mellidis1, Valentin Ordodi, Eleftheria Galatou, Dorel Săndesc, Serban Bubenek, Oana Duicu, Danina Muntean, Antigone Lazou.   

Abstract

According to a compelling body of evidence anesthetic preconditioning (APC) attenuates the deleterious consequences of ischemia-reperfusion and protects the heart through a mechanism similar to ischemic preconditioning. The present study was purported to investigate the intracellular signaling pathways activated in human myocardium in response to a preconditioning protocol with two different volatile anesthetics, namely isoflurane and sevoflurane. To this aim, phosphorylation of PKCα and -δ, ERK1/2, Akt, and GSK3β was determined at the end of the APC protocol, in human atrial samples harvested from patients undergoing open-heart surgery. The results demonstrate that preconditioning with volatile anesthetics triggers the activation of PKCδ and -α isoforms and of prosurvival kinases, ERK1/2, and Akt, while inhibiting their downstream target GSK3β during the memory phase.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24276754     DOI: 10.1007/s11010-013-1910-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  46 in total

Review 1.  Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms.

Authors:  M Zaugg; E Lucchinetti; M Uecker; T Pasch; M C Schaub
Journal:  Br J Anaesth       Date:  2003-10       Impact factor: 9.166

Review 2.  Volatile anaesthetics and cardioprotection: lessons from animal studies.

Authors:  Danina M Muntean; Valentin Ordodi; René Ferrera; Denis Angoulvant
Journal:  Fundam Clin Pharmacol       Date:  2012-07-15       Impact factor: 2.748

3.  Beta1-integrin and PTEN control the phosphorylation of protein kinase C.

Authors:  D B Parekh; R M Katso; N R Leslie; C P Downes; K J Procyk; M D Waterfield; P J Parker
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

4.  Beneficial impact of isoflurane during coronary bypass surgery on troponin I release.

Authors:  F Tomai; R De Paulis; A Penta de Peppo; L Colagrande; E Caprara; P Polisca; G De Matteis; A S Ghini; S Forlani; D Colella; L Chiariello
Journal:  G Ital Cardiol       Date:  1999-09

5.  Reactive oxygen species precede protein kinase C-delta activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection.

Authors:  R Arthur Bouwman; René J P Musters; Brechje J van Beek-Harmsen; Jaap J de Lange; Christa Boer
Journal:  Anesthesiology       Date:  2004-03       Impact factor: 7.892

6.  Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial.

Authors:  V Piriou; J Mantz; G Goldfarb; M Kitakaze; P Chiari; S Paquin; C Cornu; J-B Lecharny; P Aussage; E Vicaut; A Pons; J-J Lehot
Journal:  Br J Anaesth       Date:  2007-10-03       Impact factor: 9.166

7.  Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study.

Authors:  Karine Julier; Rafaela da Silva; Carlos Garcia; Lukas Bestmann; Philippe Frascarolo; Andreas Zollinger; Pierre-Guy Chassot; Edith R Schmid; Marko I Turina; Ludwig K von Segesser; Thomas Pasch; Donat R Spahn; Michael Zaugg
Journal:  Anesthesiology       Date:  2003-06       Impact factor: 7.892

8.  The divergent roles of protein kinase C epsilon and delta in simulated ischaemia-reperfusion injury in human myocardium.

Authors:  Vivek Sivaraman; Derek J Hausenloy; Shyam Kolvekar; Martin Hayward; John Yap; David Lawrence; Carmelo Di Salvo; Derek M Yellon
Journal:  J Mol Cell Cardiol       Date:  2009-02-25       Impact factor: 5.000

9.  Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning.

Authors:  Rafaela da Silva; Thomas Grampp; Thomas Pasch; Marcus C Schaub; Michael Zaugg
Journal:  Anesthesiology       Date:  2004-01       Impact factor: 7.892

Review 10.  Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

View more
  4 in total

Review 1.  New and revisited approaches to preserving the reperfused myocardium.

Authors:  Robert A Kloner; David A Brown; Marie Csete; Wangde Dai; James M Downey; Roberta A Gottlieb; Sharon L Hale; Jianru Shi
Journal:  Nat Rev Cardiol       Date:  2017-07-27       Impact factor: 32.419

2.  Sevoflurane-Remifentanil Versus Propofol-Remifentanil Anesthesia During Noncardiac Surgery for Patients with Coronary Artery Disease - A Prospective Study Between 2016 and 2017 at a Single Center.

Authors:  Zhongliang Dai; Miao Lin; Yali Li; Wenli Gao; Ping Wang; Juan Lin; Zhenzhen Wan; Yuanxu Jiang
Journal:  Med Sci Monit       Date:  2021-08-21

Review 3.  Exploring the modulation of hypoxia-inducible factor (HIF)-1α by volatile anesthetics as a possible mechanism underlying volatile anesthetic-induced CNS injury.

Authors:  Emma K Giles; Andrew J Lawrence; Jhodie R Duncan
Journal:  Neurochem Res       Date:  2014-07-09       Impact factor: 3.996

Review 4.  Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia.

Authors:  G Kunst; A A Klein
Journal:  Anaesthesia       Date:  2015-04       Impact factor: 6.955

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.